losartan has been researched along with Hypercalcemia in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Hypercalcemia: Abnormally high level of calcium in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mangat, H | 1 |
| Peterson, LN | 1 |
| Burns, KD | 1 |
1 other study available for losartan and Hypercalcemia
| Article | Year |
|---|---|
Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors.
Topics: Angiotensin II; Animals; Blotting, Western; Calcium; Cyclooxygenase 1; Cyclooxygenase 2; Dihydrotach | 1997 |